France· FR:66198173
ZEPATIER 50 mg/100 mg, comprimé pelliculé
A medicinal product containing elbasvir + grazoprévir monohydraté, registered in France by MERCK SHARP & DOHME (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ELBASVIR + GRAZOPRÉVIR MONOHYDRATÉ
- Manufacturer
- MERCK SHARP & DOHME (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009300617014 plaquette(s) aluminium de 7 comprimé(s)EUR 6.6
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Elbasvir + grazoprévir monohydraté in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomZepatier 50mg/100mg tabletsOriginalis B.V.
- SpainZEPATIER 50MG/100MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Sharp & Dohme B.V.
- FinlandZEPATIERMerck Sharp & Dohme B.V.
- IrelandZEPATIER 50 mg/100 mg film-coated tabletsMerck Sharp & Dohme BV,
- IcelandZepatierMerck Sharp & Dohme B.V.*
- NetherlandsZepatier 50mg/100mg, filmomhulde tabletMerck Sharp & Dohme B.V.
- PolandZepatierMerck Sharp & Dohme B.V.
- SwedenZEPATIER 50 mg/100 mg Filmdragerad tablettMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zepatier
- Liechtenstein · Zepatier
- Norway · Zepatier
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a095a75c-8aa0-4df2-b9ce-84a5359f2c5a GET /v1/drugs/a095a75c-8aa0-4df2-b9ce-84a5359f2c5a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66198173",
"date_amm": "2016-07-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/16/1119",
"substance": "ELBASVIR + GRAZOPRÉVIR MONOHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about elbasvir + grazoprévir monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.